InsidersTradesSigma
Augmedix, Inc.: management transactions · United States · SEC (Form 4)
SEC:augmedix-incUS·SEC (Form 4)Healthcare & Pharma
Browse the full management transaction log of Augmedix, Inc., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Augmedix, Inc. has recorded 1 reports. The latest transaction was reported on 21 May 2021 — Acquisition. Among the most active insiders: Ginocchio Paul. The full history is accessible without an account.
1
Insider Decl.
0
Thresholds
€40,990
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
Last declaration on 21 May 2021
Declarations1 total
Executives▲Purchase25SEC
€40,99012,600 shares@ €3.2531100.0% of flow
Common Stock
SEC:0000899243-21-020403·
Ideal exit: 13 Feb 2022 (T+270)
1 of 1 declaration
About Augmedix, Inc.
Competitively, Augmedix operated in a highly contested healthcare IT niche, facing pressure from larger EHR vendors, outsourced documentation providers, and newer ambient-scribing AI platforms. Its differentiation was based on a mix of software, service delivery, and workflow integration, particularly for enterprise health systems. A major recent milestone was the July 2024 announcement of a definitive agreement to be acquired by Commure in an all-cash transaction valued at roughly $139 million, followed by closing in October 2024 and the subsequent delisting of Augmedix shares from the NASDAQ. For French-speaking investors, Augmedix is best viewed as a U.S. digital health case study marked by rapid sector consolidation rather than a still-listed standalone equity story.
